Extracellular vesicles (EVs) such as ectosomes and exosomes have gained attention as
promising natural carriers for drug delivery. Exosomes, which range from 30 to 100 nm in …

Complexity and difficulties in wound management are pressing concerns that affect patients'
quality of life and may result in tissue infection, necrosis, and loss of local and systemic …

Lipid-based nanocarriers have been extensively investigated for their application in drug
delivery. Particularly, liposomes are now clinically established for treating various diseases …

Exosomes, as natural nanocarriers, characterized with low immunogenicity, non-cytotoxicity
and targeted delivery capability, which have advantages over synthetic nanocarriers …

Exosomes possess several inherent properties that make them ideal for biomedical
applications, including robust stability, biocompatibility, minimal immunogenicity, and the …

Diabetic wounds have imposed a significant burden on both patients and society with
prolonged healing processes hindered by dysfunctional skin repair cells. Small extracellular …

Extracellular vesicles (EVs) are widely recognized for their potential as drug delivery
systems. EVs are membranous nanoparticles shed from cells. Among their natural features …

Liver cancer is a global health challenge as it is the third leading cause of cancer death
worldwide. Hepatocellular carcinoma (HCC) is the most common type of liver cancer and is …

In recent years, small interfering RNA (siRNA) has been widely used in the treatment of
human diseases, especially tumors, and has shown great appeal. However, the clinical …

Extracellular vesicles (EVs) are membrane vesicles released into the extracellular milieu by
cells of various origins. They contain different biological cargoes, protecting them from …